Effect of Aging on the Tumoricidal Functions of Murine Peritoneal Macrophages

Natural Immunity

Volumn 15, Issue 6, 1996, Pages 285-294

  Khare, Vineeta ^a   Sodhi, Ajit ^a   Singh, Sukh Mahendra ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Aging; Cytotoxicity; iNOS; Macrophage; Oncostatin M

Indexed keywords

GAMMA INTERFERON; LIPOPOLYSACCHARIDE; NITRIC OXIDE; ONCOSTATIN M; TUMOR NECROSIS FACTOR;

AGING; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CYTOSTASIS; CYTOTOXICITY; FEMALE; MACROPHAGE ACTIVATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE;

EID: 0030319530     PISSN: 10188916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Klostergaard J: Macrophage tumoricidal mechanisms. Res Immunol 1993;144:274-276.
2. Parajuli P, Singh SM: Alteration in IL-1 and arginase activity of tumor-associated macrophages: A role in the promotion of tumor growth. Cancer Lett 1996;107:249-256.
3. Keller R, Geiges M, Keisth R: L-arginine-dependent reactive nitrogen intermediates as mediator of tumor cell killing by activated macrophages. Cancer Res 1990;15:421-425.
4. Chen Y, Bradley SF: Aging and eliciting agents: Effect on murine peritoneal macrophage monokine bioactivity. Exp Gerontol 1993;28:145-159.
5. Nathan CF: Secretory products of macrophages. J Clin Invest 1987;19: 319-326.
6. Jiang H, Stewart CA, Leu RW: Tumor-derived soluble factors synergize with interferon-gamma and LPS, IL-2 or TNF receptors for autocrine induction of NOS and enhance NO-mediated tumor cytotoxicity. Immunobiology 1995;192: 321-342.
7. Bruce AG, Linsley PS, Rose TM: Oncostatin M. Prog Growth Factor Res 1992;4:157-170.
8. Onozaki K, Matsushima K, Kleinermann ES, Tsaito T, Oppenheim JJ: Role of interleukin-1 in promoting human monocyte-mediated tumor cytotoxicity. J Immunol 1985;135: 314-320.
9. Mackinodan T, Kay MMB: Age influence on the immune system. Adv Immunol 1980;29:287-294.
10. Bloom ET, Horvath JA: Cellular and molecular mechanisms of the IL-12-induced increase in allo-specific murine cytolytic T cell activity: Implications for the age-related decline in CTL. J Immunol 1994;152: 4242-4254.
11. Hannet I, Erkeller F, Lydyard P, Deneys V, De Bruyere M: Developmental and maturational changes in human blood lymphocyte populations. Immunol Today 1992;13: 215-218.
12. Davilla DR, Edwards CK, Arkins S, Simon J, Kelley KW: Interferon-gamma-induced priming for secretion of Superoxide anion and tumor necrosis factor-alpha declines in macrophages from aged rats. FASEB J 1990;4:2906-2911.
13. Ding A, Hwang S, Schwab R: Effect of aging on murine macrophages: Diminished response to interferon gamma for enhanced oxidative metabolism. J Immunol 1994;153: 2146-2152.
14. Vetricka V, Tlaskalova-Hogenova H, Pospisil M: Impaired antigen presenting function of macrophages from aged mice. Immunol Invest 1985;14:105-109.
15. Wustrow TPU, Denny TN, Fernandes G, Good RA: Changes in macrophages and their functions with aging in C57BL/6J, AKR/J, and SJL/J mice. Cell Immunol 1982;69:227-234.
16. Gutowski JK, Weksler ME: Studies on the syngenic mixed lymphocyte reaction. II. Decline in the syngenic mixed lymphocyte reaction with age. Immunology 1982;46:801-808.
17. McLachlan JA, Serkin CD, Morrey KM, Bakouche O: Antitumoral properties of aged human monocytes. J Immunol 1995;154:832-843.
18. Chen LC, Pace JL, Russel SW, Morrison DC: Altered regulation of inducible nitric oxide synthase expression in macrophages from senescent mice. Infect Immunol 1996;64: 4288-4298.
19. Bradley SF, Vibagool A, Kunkel SL, Kauffman CA: Monokine secretion in aging and protein malnutrition. J Leukoc Biol 1989;45:510-514.
20. Wigle WO: The effect of aging on cytokine release and associated immunologic functions. Immunol Allergy Clin N Am 1993;13:551-569.
21. Jorens PG, Matthys KE, Bult H: Modulation of nitric oxide synthase activity in macrophages. Mediators Inflamm 1995;4:75-89.
22. Key ME, Hoyer L, Bucana C, Hanna MG: Mechanism of macrophage-mediated tumor cytolysis. Adv Exp Med Biol 1982;146:265-310.
23. Singh SM, Sodhi A: Interaction between cisplatin-treated macrophages with Dalton's lymphoma cells in vitro. Exp Cell Biol 1988;56: 1-11.
24. Sone S, Moriguchi S, Shimizu E, Ogushi F, Tsubura E: In vitro generation of tumoricidal properties in human alveolar macrophages following interaction with endotoxin. Cancer Res 1982;42:2227-2231.
25. Sodhi A, Singh SM: Release of cytolytic factor(s) by murine macrophages in vitro on treatment with cisplatin. Int J Immunopharmacol 1986;8:701-707.
26. Singh SM, Singh RK, Sodhi A: Effect of allogenic Dalton's lymphoma cells on the activation of murine peritoneal macrophages to tumoricidal state by cisplatin and LPS. Neoplasma 1992;39:151-155.
27. Sodhi A, Suresh A, Singh SM: In vitro activation of rGM-CSF-derived bone marrow macrophages by cisplatin and LPS. Immunol Cell Biol 1991;69:235-241.
28. Ding AH, Nathan CF, Stuehr DJ: Release of reactive nitrogen intermediates and reactive oxygen intermediates from murine peritoneal macrophages. J Immunol 1988;141: 2407-2412.
29. Prajuli P, Singh SM, Kumar A: Effect of cisplatin and FK565 on the activation of tumor-associated and bone marrow-derived macrophages by Dalton's lymphoma. Int J Immunopharmacol 1995;17:1-7.
30. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976;72:248-254.
31. Weinstein SL, Gold MR, DeFranco AL: Bacterial LPS stimulate protein tyrosine phosphorylation in macrophages. Proc Natl Acad Sci USA 1991;88:4148-4152.
32. Futamura Y: Age associated changes in TNF-α receptor on peripheral blood monocytes and bone marrow macrophages from ICR mice and Wistar rats. Exp Anim 1995;44:151-157.
33. Alvarez E, Machado A, Sobrino F, Santa MC: Nitric oxide and superoxide anion production decreases with age in resident and activated rat peritoneal macrophages. Cell Immunol 1996;169:152-155.
34. Chen Y, Johnson AG: In vivo activation of macrophages by prolactin from young and aging mice. Int J Immunopharmacol 1988;15:39-45.